Search

Your search keyword '"Straumann, A."' showing total 9 results
Start Over Author "Straumann, A." Language french
9 results on '"Straumann, A."'

2. Margrit Tröhler, Offene Welten ohne Helden

Author

Straumann, Patrick

Abstract

Phénomène clé de la production cinématographique des années 1990, les films choraux connaissent en général un accueil mitigé. Si l’on peut les créditer de refléter de façon adéquate la déliaison sociale dont ils procèdent, ils se voient également exposés aux reproches d’être conçus en fonction de la seule distribution ou encore de recourir à des solutions de facilité dans la conception des personnages. Entrés en force dans le paysage hollywoodien avec l’œuvre tardive de Robert Altman, les fil...

Published
2016

4. Wieder mehr Wirtschaftsgeschichte der Schweiz im 19. Jahrhundert - ein Plädoyer.

Author

Straumann, Tobias

Subjects
ECONOMIC history, INDUSTRIAL revolution, CAPITAL investments, WORK environment
Abstract

The article discusses economic history of Switzerland in the 19th century. Topics discussed include role of social origins of entrepreneurs and the sources of investment capital in industrial revolution; information on working conditions of workers and their children, about factory regulations or the pauperism of the 1830s and 1840s; and role of freedom of trade and industry and the Napoleonic continental blockade in early industrialization of Switzerland.

Published
2021
Full Text
View/download PDF

5. [Infliximab--practical guidelines for the treatment of Crohn's disease]

Author

Bauerfeind P, Beglinger C, Beltinger J, Christian Braegger, Eigenmann F, Fried M, Guyot J, Hürlimann R, Michetti P, Seibold F, and Straumann A

Subjects
Crohn Disease, Gastrointestinal Agents, Antibodies, Monoclonal, Humans, Infliximab
Abstract

Infliximab is a monoclonal chimeric antibody, with high affinity and specificity for tumour necrosis factor alpha (TNFalpha) that plays a central role in the pathogenesis of immune mediated inflammatory disorders including Crohn's disease and ulcerative colitis. Globally over 600000 patients have been treated with infliximab to date. This global experience led to a better definition of the overall safety and efficacy profile of this medication. The goal of the present recommendations is to provide practical information to physicians involved in the care of patients with inflammatory bowel disease.

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results